This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Quetiapine 200 mg
- Starting date:
- May 17, 2013
- Posting date:
- June 3, 2013
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety, Contamination
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-33865
Recalled Products
- Quetiapine 200 mg
Reason
Potential cross-contamination of trace amounts of Clindamycin in Quetiapine Active Pharmaceutical Ingredient during the manufacturing process.
Depth of distribution
Distributed to wholesalers/pharmacies across Canada.
Affected products
A. Quetiapine 200 mg
DIN, NPN, DIN-HIM
DIN 02353199
Dosage form
- Tablet
Strength
- 200 mg
Lot or serial number
- All lots
Companies
- Recalling Firm
-
Sanis Health Inc.
333 Champlain Street, Suite 102
Dieppe
E1A 1P2
New Brunswick
CANADA
- Marketing Authorization Holder
-
Sanis Health Inc.
333 Champlain Street, Suite 102
Dieppe
E1A 1P2
New Brunswick
CANADA